These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10828965)

  • 1. Inactivation of cysteine proteases by (acyloxy)methyl ketones using S'-P' interactions.
    Dai Y; Hedstrom L; Abeles RH
    Biochemistry; 2000 May; 39(21):6498-502. PubMed ID: 10828965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inactivation of cathepsins S and L by peptidyl (acyloxy)methyl ketones.
    Brömme D; Smith RA; Coles PJ; Kirschke H; Storer AC; Krantz A
    Biol Chem Hoppe Seyler; 1994 May; 375(5):343-7. PubMed ID: 8074807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.
    LaLonde JM; Zhao B; Smith WW; Janson CA; DesJarlais RL; Tomaszek TA; Carr TJ; Thompson SK; Oh HJ; Yamashita DS; Veber DF; Abdel-Meguid SS
    J Med Chem; 1998 Nov; 41(23):4567-76. PubMed ID: 9804696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.
    Krantz A; Copp LJ; Coles PJ; Smith RA; Heard SB
    Biochemistry; 1991 May; 30(19):4678-87. PubMed ID: 2029515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases.
    Dolle RE; Singh J; Whipple D; Osifo IK; Speier G; Graybill TL; Gregory JS; Harris AL; Helaszek CT; Miller RE
    J Med Chem; 1995 Jan; 38(2):220-2. PubMed ID: 7830263
    [No Abstract]   [Full Text] [Related]  

  • 8. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
    Perlman N; Hazan M; Shokhen M; Albeck A
    Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.
    Thornberry NA; Peterson EP; Zhao JJ; Howard AD; Griffin PR; Chapman KT
    Biochemistry; 1994 Apr; 33(13):3934-40. PubMed ID: 8142397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
    Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
    Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I.
    Chatterjee S; Ator MA; Bozyczko-Coyne D; Josef K; Wells G; Tripathy R; Iqbal M; Bihovsky R; Senadhi SE; Mallya S; O'Kane TM; McKenna BA; Siman R; Mallamo JP
    J Med Chem; 1997 Nov; 40(23):3820-8. PubMed ID: 9371247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.
    Darkins P; Gilmore BF; Hawthorne SJ; Healy A; Moncrieff H; McCarthy N; McKervey MA; Brömme D; Pagano M; Walker B
    Chem Biol Drug Des; 2007 Mar; 69(3):170-9. PubMed ID: 17441903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
    Wikstrom P; Kirschke H; Stone S; Shaw E
    Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of alpha,beta-unsaturated ketone-based probes for papain-family cysteine proteases.
    Yang Z; Fonović M; Verhelst SH; Blum G; Bogyo M
    Bioorg Med Chem; 2009 Feb; 17(3):1071-8. PubMed ID: 18343672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
    Therrien C; Lachance P; Sulea T; Purisima EO; Qi H; Ziomek E; Alvarez-Hernandez A; Roush WR; Ménard R
    Biochemistry; 2001 Mar; 40(9):2702-11. PubMed ID: 11258881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
    Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
    Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
    Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.